FDA Inspection 1298968 — Biomat USA Inc

Biomat USA Inc — FEI 3022988848

The FDA completed an inspection of Biomat USA Inc on Jan 12, 2026 in Mansfield, OH. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Jan 12, 2026
Fiscal Year
2026
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Mansfield, OH (United States)

Citations

IDCFRDescription
15421 CFR 606.160(a)(1)Concurrent documentation

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.